Natco News

Shares in Natco Pharma plunged as much as 11 per cent, after the company said that it has received 483 observations from the US FDA. The stock of Natco Pharma last trading at Rs 417, down 11.1 per cent in trade. ...

NATCO Pharma has said that the US Court of Appeals for the Federal Circuit ruling, has reversed a district court's finding related to Teva's US Patent for Copaxone. This would essentially mean that NATCO could launch the generic Copaxone - ...